Event Type
Disclosure
Mandatory
Variant
8-K
is unaudited and subject to adjustment. Item 7.01 Regulation FD Disclosure A copy of the press release referenced in Item 2.02 hereof is filed as Exhibit 99
. Except to the extent described in Item 8.01 hereof, the information contained in this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed to be “
are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including with respect to statements related to our c
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release issued by NextCure, Inc. January 23, 2026 99.2 NextCure, Inc. Pres